• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44/CD44v6:癌症起始细胞维持和肿瘤进展中的可靠“伙伴”

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.

作者信息

Wang Zhe, Zhao Kun, Hackert Thilo, Zöller Margot

机构信息

Department of Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong, China.

Pancreas Section, University Hospital of Surgery, Heidelberg, Germany.

出版信息

Front Cell Dev Biol. 2018 Aug 28;6:97. doi: 10.3389/fcell.2018.00097. eCollection 2018.

DOI:10.3389/fcell.2018.00097
PMID:30211160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6122270/
Abstract

Metastasis is the leading cause of cancer death, tumor progression proceeding through emigration from the primary tumor, gaining access to the circulation, leaving the circulation, settling in distant organs and growing in the foreign environment. The capacity of a tumor to metastasize relies on a small subpopulation of cells in the primary tumor, so called cancer-initiating cells (CIC). CIC are characterized by sets of markers, mostly membrane anchored adhesion molecules, CD44v6 being the most frequently recovered marker. Knockdown and knockout models accompanied by loss of tumor progression despite unaltered primary tumor growth unraveled that these markers are indispensable for CIC. The unexpected contribution of marker molecules to CIC-related activities prompted research on underlying molecular mechanisms. This review outlines the contribution of CD44, particularly CD44v6 to CIC activities. A first focus is given to the impact of CD44/CD44v6 to inherent CIC features, including the crosstalk with the niche, apoptosis-resistance, and epithelial mesenchymal transition. Following the steps of the metastatic cascade, we report on supporting activities of CD44/CD44v6 in migration and invasion. These CD44/CD44v6 activities rely on the association with membrane-integrated and cytosolic signaling molecules and proteases and transcriptional regulation. They are not restricted to, but most pronounced in CIC and are tightly regulated by feedback loops. Finally, we discuss on the engagement of CD44/CD44v6 in exosome biogenesis, loading and delivery. exosomes being the main acteurs in the long-distance crosstalk of CIC with the host. In brief, by supporting the communication with the niche and promoting apoptosis resistance CD44/CD44v6 plays an important role in CIC maintenance. The multifaceted interplay between CD44/CD44v6, signal transducing molecules and proteases facilitates the metastasizing tumor cell journey through the body. By its engagement in exosome biogenesis CD44/CD44v6 contributes to disseminated tumor cell settlement and growth in distant organs. Thus, CD44/CD44v6 likely is the most central CIC biomarker.

摘要

转移是癌症死亡的主要原因,肿瘤进展过程包括从原发肿瘤迁移、进入循环系统、离开循环系统、在远处器官定居并在异质环境中生长。肿瘤的转移能力依赖于原发肿瘤中的一小部分细胞亚群,即所谓的癌症起始细胞(CIC)。CIC具有一系列标志物特征,大多是膜锚定黏附分子,其中CD44v6是最常检测到的标志物。敲低和敲除模型显示,尽管原发肿瘤生长未改变,但肿瘤进展却出现缺失,这表明这些标志物对CIC不可或缺。标志物分子对CIC相关活动的意外作用促使人们对其潜在分子机制展开研究。本综述概述了CD44,尤其是CD44v6对CIC活动的作用。首先关注CD44/CD44v6对CIC固有特征的影响,包括与微环境的相互作用、抗凋亡能力和上皮-间质转化。按照转移级联的步骤,我们报告了CD44/CD44v6在迁移和侵袭中的支持作用。这些CD44/CD44v6活动依赖于与膜整合和胞质信号分子、蛋白酶以及转录调控的关联。它们不仅限于CIC,但在CIC中最为显著,并受到反馈回路的严格调控。最后,我们讨论了CD44/CD44v6在外泌体生物发生、装载和传递中的作用。外泌体是CIC与宿主进行长距离相互作用的主要参与者。简而言之,通过支持与微环境的通讯并促进抗凋亡能力,CD44/CD44v6在CIC维持中发挥重要作用。CD44/CD44v6、信号转导分子和蛋白酶之间的多方面相互作用促进了转移肿瘤细胞在体内的迁移过程。通过参与外泌体生物发生,CD44/CD44v6有助于播散肿瘤细胞在远处器官的定居和生长。因此,CD44/CD44v6可能是最核心的CIC生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/f94336f68016/fcell-06-00097-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/735ea1f6f3ff/fcell-06-00097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/e168524d9d34/fcell-06-00097-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/38cfec53609a/fcell-06-00097-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/bd7d51523dd9/fcell-06-00097-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/f94336f68016/fcell-06-00097-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/735ea1f6f3ff/fcell-06-00097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/e168524d9d34/fcell-06-00097-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/38cfec53609a/fcell-06-00097-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/bd7d51523dd9/fcell-06-00097-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/6122270/f94336f68016/fcell-06-00097-g0005.jpg

相似文献

1
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.CD44/CD44v6:癌症起始细胞维持和肿瘤进展中的可靠“伙伴”
Front Cell Dev Biol. 2018 Aug 28;6:97. doi: 10.3389/fcell.2018.00097. eCollection 2018.
2
CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.具有CD44v6功能的肿瘤外泌体可促进胰腺癌细胞和结肠直肠癌细胞的迁移、侵袭及癌症起始细胞标志物的表达。
Oncotarget. 2016 Aug 23;7(34):55409-55436. doi: 10.18632/oncotarget.10580.
3
Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.胰腺癌起始细胞外泌体信息传递至非起始细胞:CD44v6 在重编程中的重要性。
J Exp Clin Cancer Res. 2019 Mar 19;38(1):132. doi: 10.1186/s13046-019-1129-8.
4
The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.胰腺癌起始细胞标志物CD44v6影响转录、翻译和信号传导:对外泌体组成和传递的影响
J Oncol. 2019 Aug 7;2019:3516973. doi: 10.1155/2019/3516973. eCollection 2019.
5
CD44 and EpCAM: cancer-initiating cell markers.CD44和上皮细胞黏附分子:癌症起始细胞标志物。
Curr Mol Med. 2008 Dec;8(8):784-804. doi: 10.2174/156652408786733667.
6
Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.Claudin7 依赖性外泌体促进非转移肿瘤细胞的重编程。
Int J Cancer. 2019 Oct 15;145(8):2182-2200. doi: 10.1002/ijc.32312. Epub 2019 May 3.
7
Exosomes, metastases, and the miracle of cancer stem cell markers.外泌体、转移和癌症干细胞标志物的奇迹。
Cancer Metastasis Rev. 2019 Jun;38(1-2):259-295. doi: 10.1007/s10555-019-09793-6.
8
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.CD44变体6与晚期上皮性卵巢癌患者的腹膜播散及不良预后相关。
Cancer Sci. 2015 Oct;106(10):1421-8. doi: 10.1111/cas.12765. Epub 2015 Sep 21.
9
Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.胰腺癌进展中的“乒乓”肿瘤与宿主
Front Oncol. 2019 Dec 16;9:1359. doi: 10.3389/fonc.2019.01359. eCollection 2019.
10
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.上皮细胞黏附分子(EpCAM)、紧密连接蛋白-7(claudin-7)、CD44变异体同工型和四跨膜蛋白复合物促进结直肠癌进展。
Mol Cancer Res. 2007 Jun;5(6):553-67. doi: 10.1158/1541-7786.MCR-06-0384.

引用本文的文献

1
CD44v6 CAR-T Cells Target DNMT3A-Mutant AML: Synergistic Enhancement by Decitabine.CD44v6嵌合抗原受体T细胞靶向DNMT3A突变的急性髓系白血病:地西他滨的协同增强作用
Curr Med Sci. 2025 Aug 25. doi: 10.1007/s11596-025-00097-1.
2
Targets for CAR Therapy in Multiple Myeloma.多发性骨髓瘤中CAR疗法的靶点
Int J Mol Sci. 2025 Jun 24;26(13):6051. doi: 10.3390/ijms26136051.
3
CAR-T cell therapy for cancer: current challenges and future directions.用于癌症治疗的嵌合抗原受体T细胞疗法:当前挑战与未来方向

本文引用的文献

1
Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.通过摄取肝癌细胞分泌的外泌体来观察人脐静脉内皮细胞的血管生成。
Sci Rep. 2018 Apr 30;8(1):6765. doi: 10.1038/s41598-018-24563-0.
2
Exosome: Function and Role in Cancer Metastasis and Drug Resistance.外泌体:在癌症转移和耐药性中的功能与作用
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818763450. doi: 10.1177/1533033818763450.
3
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Signal Transduct Target Ther. 2025 Jul 4;10(1):210. doi: 10.1038/s41392-025-02269-w.
4
GPNMB marks a quiescent cell population in melanoma and promotes metastasis formation.GPNMB标记黑色素瘤中的静止细胞群并促进转移形成。
EMBO Rep. 2025 Jun 17. doi: 10.1038/s44319-025-00501-w.
5
CD44 Variant Expression in Follicular Cell-Derived Thyroid Cancers: Implications for Overcoming Multidrug Resistance.CD44变异体在滤泡细胞源性甲状腺癌中的表达:对克服多药耐药性的意义
Molecules. 2025 Apr 24;30(9):1899. doi: 10.3390/molecules30091899.
6
Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma.基因表达谱分析确定CAV1、CD44和TFRC为多发性骨髓瘤的潜在诊断标志物和治疗靶点。
Cell Biochem Biophys. 2025 Apr 17. doi: 10.1007/s12013-025-01743-0.
7
CD44 variant exons induce chemoresistance by modulating cell death pathways.CD44可变外显子通过调节细胞死亡途径诱导化学抗性。
Front Cell Dev Biol. 2025 Mar 6;13:1508577. doi: 10.3389/fcell.2025.1508577. eCollection 2025.
8
CD44v6-mediated regulation of gastric cancer stem cells: a potential therapeutic target.CD44v6介导的胃癌干细胞调控:一个潜在的治疗靶点。
Clin Exp Med. 2025 Mar 12;25(1):80. doi: 10.1007/s10238-025-01611-4.
9
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity.在经临床测试的溶瘤腺免疫疗法中,T细胞衔接器的额外表达可将肿瘤浸润的无关T细胞重定向至癌细胞,以增强抗肿瘤免疫力。
J Immunother Cancer. 2024 Dec 9;12(12):e009741. doi: 10.1136/jitc-2024-009741.
10
Microgravity as a Tool to Investigate Cancer Induction in Pleura Mesothelial Cells.微重力作为研究胸膜间皮细胞癌症诱导的工具。
Curr Issues Mol Biol. 2024 Sep 27;46(10):10896-10912. doi: 10.3390/cimb46100647.
外泌体在癌症进展中的多效性作用:诊断和治疗意义 [更正]。
Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17.
4
Extracellular vesicles: important collaborators in cancer progression.细胞外囊泡:癌症进展中的重要合作者。
Essays Biochem. 2018 May 15;62(2):149-163. doi: 10.1042/EBC20170080.
5
Exosomes as emerging players in cancer biology.外泌体:癌症生物学中的新兴角色
Biochimie. 2018 Dec;155:2-10. doi: 10.1016/j.biochi.2018.03.006. Epub 2018 Mar 16.
6
Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10.鼻咽癌来源外泌体中的转移相关 miR-23a 通过抑制新型靶基因 TSGA10 介导血管生成。
Oncogene. 2018 May;37(21):2873-2889. doi: 10.1038/s41388-018-0183-6. Epub 2018 Mar 9.
7
Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview.癌症患者循环外泌体中的小RNA:一篇综述
High Throughput. 2017 Oct 6;6(4):13. doi: 10.3390/ht6040013.
8
Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.外泌体 miRNAs 作为新型癌症生物标志物:挑战与机遇。
J Cell Physiol. 2018 Sep;233(9):6370-6380. doi: 10.1002/jcp.26481. Epub 2018 Mar 25.
9
Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.内皮细胞衍生的白细胞介素-6通过产生朝向血管的趋化梯度来诱导癌症干细胞的迁移。
Oncotarget. 2017 Nov 1;8(59):100339-100352. doi: 10.18632/oncotarget.22225. eCollection 2017 Nov 21.
10
The influence of tumour-derived extracellular vesicles on local and distal metastatic dissemination.肿瘤细胞外囊泡对局部和远处转移扩散的影响。
Mol Aspects Med. 2018 Apr;60:15-26. doi: 10.1016/j.mam.2017.11.012. Epub 2017 Dec 6.